General Information
Drug ID
DR00845
Drug Name
Daidzein
Synonyms
7-Dihydroxyisoflavone; 4',7-Dihydroxy-iso-flavone; 4',7-Dihydroxyisoflavone; 4,7-Dihydroxyisoflavone; 486-66-8; 4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-hydroxyphenyl)-; 7,4'-Dihydroxyisoflavone; 7,4'-dihydroxyisoflavone; 7-Hydroxy-3-(4-hydroxyphenyl)-4-benzopyrone; 7-Hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; 7-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one; 7-hydroxy-3-(4-hydroxyphenyl)chromen-4-one; BRN 0231523; CCRIS 7600; CHEMBL8145; DIADZEIN; Daidzein; Daidzeol; EINECS 207-635-4; K 251b; UNII-6287WC5J2L; d-(+)-alpha-methylbenzylamine
Drug Type
Small molecular drug
Indication Low Serum Lipid Levels [ICD11: 5C81] Phase 4 [1]
Structure
3D MOL 2D MOL
Formula
C15H10O4
Canonical SMILES
C1=CC(=CC=C1C2=COC3=C(C2=O)C=CC(=C3)O)O
InChI
InChI=1S/C15H10O4/c16-10-3-1-9(2-4-10)13-8-19-14-7-11(17)5-6-12(14)15(13)18/h1-8,16-17H
InChIKey
ZQSIJRDFPHDXIC-UHFFFAOYSA-N
CAS Number
CAS 486-66-8
Pharmaceutical Properties Molecular Weight 254.24 Topological Polar Surface Area 66.8
Heavy Atom Count 19 Rotatable Bond Count 1
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 4
XLogP
2.5
PubChem CID
5281708
ChEBI ID
CHEBI:28197
TTD Drug ID
D0SY2M
DT(s) Transporting This Drug BCRP Transporter Info Breast cancer resistance protein Substrate [2]
References
1 ClinicalTrials.gov (NCT01497977) Phytoestrogen Supplementation in Postmenopausal Women
2 Effect of breast cancer resistance protein (Bcrp/Abcg2) on the disposition of phytoestrogens. Mol Pharmacol. 2007 Oct;72(4):967-75.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.